STERIS Plc Q3 Profit Surges 15% to $120M

[Para 1: The Lead] STERIS Plc (STXS) reported a 15% increase in Q3 profit to $120 million, surpassing analyst expectations, on strong performance in its healthcare and laboratory segments. The company's stock surged 7% in after-hours trading following the earnings release. [Para 2-3: Supporting details & Context] Revenue climbed 10% to $550 million, driven by robust demand in emerging markets and a 7% organic growth. Adjusted earnings per share (EPS) rose to $2.20, up from $1.92 in the same period last year. STERIS attributed the growth to successful cost management and strategic acquisitions. The company expects Q4 earnings to be in the range of $2.30 to $2.40 per share, reflecting continued momentum.